A Michotte - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

A Michotte

Showing results (41-50 of 44) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 44 results.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 4, 2009

Stratified phase II trial of cetuximab in patients with recurrent high-grade gliomaB Neyns, J Sadones, E Joosens, et al.

Journal of Neuro-Oncology|March 4, 2016

Randomized phase II study of axitinib versus physicians best alternative choice of therapy in patients with recurrent glioblastomaJ Duerinck, S Du Four, F Vandervorst, et al.

Journal of Neuro-Oncology|October 9, 2017

Randomized phase II trial comparing axitinib with the combination of axitinib and lomustine in patients with recurrent glioblastomaJ Duerinck, S Du Four, F Bouttens, et al.

European Journal of Cancer (Oxford, England : 1990)|October 24, 2008

MGMT promoter hypermethylation correlates with a survival benefit from temozolomide in patients with recurrent anaplastic astrocytoma but not glioblastomaJ Sadones, A Michotte, P Veld, et al.

Pageof 5

Search research articles

Showing results (41-50 of 44) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 44 results.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 4, 2009

Stratified phase II trial of cetuximab in patients with recurrent high-grade gliomaB Neyns, J Sadones, E Joosens, et al.

Journal of Neuro-Oncology|March 4, 2016

Randomized phase II study of axitinib versus physicians best alternative choice of therapy in patients with recurrent glioblastomaJ Duerinck, S Du Four, F Vandervorst, et al.

Journal of Neuro-Oncology|October 9, 2017

Randomized phase II trial comparing axitinib with the combination of axitinib and lomustine in patients with recurrent glioblastomaJ Duerinck, S Du Four, F Bouttens, et al.

European Journal of Cancer (Oxford, England : 1990)|October 24, 2008

MGMT promoter hypermethylation correlates with a survival benefit from temozolomide in patients with recurrent anaplastic astrocytoma but not glioblastomaJ Sadones, A Michotte, P Veld, et al.

Pageof 5